Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2006;113:338-344
Published online before print January 16, 2006, doi: 10.1161/CIRCULATIONAHA.105.580811
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
113/3/338    most recent
CIRCULATIONAHA.105.580811v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bezzina, C. R.
Right arrow Articles by Wilde, A. A.M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bezzina, C. R.
Right arrow Articles by Wilde, A. A.M.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*UniGene
*Genetics Home Reference
Related Collections
Right arrow Arrythmias-basic studies
Right arrow Gene expression
Right arrow Arrhythmias, clinical electrophysiology, drugs
Right arrow Epidemiology
Right arrow Genetics of cardiovascular disease
Right arrowRelated Article

(Circulation. 2006;113:338-344.)
© 2006 American Heart Association, Inc.


Arrhythmia/Electrophysiology

Common Sodium Channel Promoter Haplotype in Asian Subjects Underlies Variability in Cardiac Conduction

Connie R. Bezzina, PhD*; Wataru Shimizu, MD, PhD*; Ping Yang, PhD*; Tamara T. Koopmann, BSc; Michael W.T. Tanck, PhD; Yoshihiro Miyamoto, MD, PhD; Shiro Kamakura, MD, PhD; Dan M. Roden, MD; Arthur A.M. Wilde, MD, PhD

From the Experimental and Molecular Cardiology Group, Department of Experimental Cardiology (C.R.B., T.T.K., A.A.M.W.), Department of Clinical Genetics (C.R.B.), and Department of Clinical Epidemiology and Biostatistics (M.W.T.T.), Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands; Division of Cardiology, Department of Internal Medicine (W.S., S.K.), and Laboratory of Molecular Genetics (Y.M.), National Cardiovascular Center, Suita, Osaka, Japan; and Department of Medicine and Pharmacology, Division of Clinical Pharmacology, Vanderbilt University School of Medicine, Nashville, Tenn (P.Y., D.M.R.).

Correspondence to Connie R. Bezzina, PhD, Experimental and Molecular Cardiology Group, Room M0–105, Department of Experimental Cardiology, Academic Medical Center, Meibergdreef 9, 1105 AZ Amsterdam, Netherlands. E-mail C.R.Bezzina{at}amc.uva.nl

Received August 3, 2005; revision received September 15, 2005; accepted October 11, 2005.

Background— Reduced cardiac sodium current slows conduction and renders the heart susceptible to ventricular fibrillation. Loss of function mutations in SCN5A, encoding the cardiac sodium channel, are one cause of the Brugada syndrome, associated with slow conduction and a high incidence of ventricular fibrillation, especially in Asians. In this study, we tested the hypothesis that an SCN5A promoter polymorphism common in Asians modulates variability in cardiac conduction.

Methods and Results— Resequencing 2.8 kb of SCN5A promoter identified a haplotype variant consisting of 6 polymorphisms in near-complete linkage disequilibrium that occurred at an allele frequency of 22% in Asian subjects and was absent in whites and blacks. Reporter activity of this variant haplotype, designated HapB, in cardiomyocytes was reduced 62% compared with wild-type haplotype (P=0.006). The relationship between SCN5A promoter haplotype and PR and QRS durations, indexes of conduction velocity, was then analyzed in a cohort of 71 Japanese Brugada syndrome subjects without SCN5A mutations and in 102 Japanese control subjects. In both groups, PR and QRS durations were significantly longer in HapB individuals (P≤0.002) with a gene-dose effect. In addition, up to 28% and 48% of variability in PR and QRS durations, respectively, were attributable to this haplotype. The extent of QRS widening during challenge with sodium channel blockers, known to be arrhythmogenic in Brugada syndrome and other settings, was also genotype dependent (P=0.002).

Conclusions— These data demonstrate that genetically determined variable sodium channel transcription occurs in the human heart and is associated with variable conduction velocity, an important contributor to arrhythmia susceptibility.


 

CLINICAL PERSPECTIVE


Related Article:

Promoting Arrhythmia Susceptibility
T. Jared Bunch and Michael J. Ackerman
Circulation 2006 113: 330-332. [Extract] [Full Text]



This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
M. Bebarova, T. O'Hara, J. L. M. C. Geelen, R. J. Jongbloed, C. Timmermans, Y. H. Arens, L.-M. Rodriguez, Y. Rudy, and P. G. A. Volders
Subepicardial phase 0 block and discontinuous transmural conduction underlie right precordial ST-segment elevation by a SCN5A loss-of-function mutation
Am J Physiol Heart Circ Physiol, July 1, 2008; 295(1): H48 - H58.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
J. Francis and C. Antzelevitch
Atrial Fibrillation and Brugada Syndrome
J. Am. Coll. Cardiol., March 25, 2008; 51(12): 1149 - 1153.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
C. Antzelevitch
Role of spatial dispersion of repolarization in inherited and acquired sudden cardiac death syndromes
Am J Physiol Heart Circ Physiol, October 1, 2007; 293(4): H2024 - H2038.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
R. Coronel, G. Berecki, and T. Opthof
Why the Brugada syndrome is not yet a disease: Syndromes, diseases, and genetic causality
Cardiovasc Res, December 1, 2006; 72(3): 361 - 363.
[Full Text] [PDF]


Home page
CirculationHome page
M. Vatta, M. J. Ackerman, B. Ye, J. C. Makielski, E. E. Ughanze, E. W. Taylor, D. J. Tester, R. C. Balijepalli, J. D. Foell, Z. Li, et al.
Mutant Caveolin-3 Induces Persistent Late Sodium Current and Is Associated With Long-QT Syndrome
Circulation, November 14, 2006; 114(20): 2104 - 2112.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
S. G. Priori and C. Napolitano
Molecular Underpinning of "Good Luck"
Circulation, August 1, 2006; 114(5): 360 - 362.
[Full Text] [PDF]


Home page
CirculationHome page
T. J. Bunch and M. J. Ackerman
Promoting Arrhythmia Susceptibility
Circulation, January 24, 2006; 113(3): 330 - 332.
[Full Text] [PDF]